AbbVie Biotherapeutics Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for AbbVie Biotherapeutics Inc..The latest application filed is for "abt-165 in combination with folinic acid, 5-fluorouracil, and irinotecan for the treatment of cancers".
Company Profile
40.84.78
- AbbVie Biotherapeutics Inc. - Redwood City CA US
- AbbVie Biotherapeutics Inc. - South San Francisco CA US
- Abbvie Biotherapeutics Inc. - Redwood Ctiy CA
Patent Activity
| Patent | Date |
|---|---|
| Abt-165 In Combination With Folinic Acid, 5-fluorouracil, And Irinotecan For The Treatment Of Cancers App 20220211846 - Naumovski; Louie | 2022-07-07 |
| Anti-cd40 Antibodies And Their Uses App 20220119542 - COHEN; Diane Sau Mun ; et al. | 2022-04-21 |
| Anti-ox40 Antibodies And Their Uses App 20220112304 - HARDING; Fiona A. | 2022-04-14 |
| Anti-cd40 Antibodies And Their Uses App 20210277137 - COHEN; Diane Sau Mun ; et al. | 2021-09-09 |
| Anti-huLRRC15 antibody drug conjugates and methods for their use Grant 11,045,480 - Gish , et al. June 29, 2 | 2021-06-29 |
| Anti-cd40 Antibody And Their Uses App 20210024642 - COHEN; Diane Sau Mun ; et al. | 2021-01-28 |
| Anti-ox40 Antibodies And Their Uses App 20210017289 - HARDING; Fiona A. | 2021-01-21 |
| Anti-4-1BB antibodies and their uses Grant 10,875,921 - Akamatsu , et al. December 29, 2 | 2020-12-29 |
| Anti-CD40 antibody Grant 10,844,131 - Cohen , et al. November 24, 2 | 2020-11-24 |
| Anti-pd-1 Antibodies And Their Uses App 20200317808 - AFAR; Daniel E.H. ; et al. | 2020-10-08 |
| Anti-cd25 Antibodies And Their Uses App 20200308290 - AKAMATSU; Yoshiko ; et al. | 2020-10-01 |
| Anti-PD-1 antibodies and their uses Grant 10,730,953 - Afar , et al. | 2020-08-04 |
| ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE App 20200215200A1 - | 2020-07-09 |
| Anti-ox40 Antibodies And Their Uses App 20200181282 - HARDING; Fiona A. | 2020-06-11 |
| Dac Hyp Compositions And Methods App 20200157230 - HARTMAN; Taymar E. ; et al. | 2020-05-21 |
| Anti-OX40 antibodies and their uses Grant 10,604,584 - Harding | 2020-03-31 |
| Anti-cMet antibody drug conjugates and methods for their use Grant 10,603,389 - Allan , et al. | 2020-03-31 |
| Anti-CD40 antibodies Grant 10,597,460 - Cohen , et al. | 2020-03-24 |
| Anti-ox40 Antibodies And Their Uses App 20200048363 - HARDING; Fiona A. | 2020-02-13 |
| Anti-OX40 antibodies and their uses Grant 10,556,962 - Harding Feb | 2020-02-11 |
| Anti-cd40 Antibodies App 20200040090 - COHEN; Diane Sau Mun ; et al. | 2020-02-06 |
| Anti-pd-1 Antibodies And Their Uses App 20200040098 - AFAR; Daniel E.H. ; et al. | 2020-02-06 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20200031929 - WILLIAMS; Marna ; et al. | 2020-01-30 |
| Anti-cd40 Antibodies And Their Uses App 20200010558 - COHEN; Diane Sau Mun ; et al. | 2020-01-09 |
| Anti-CD40 antibodies Grant 10,519,243 - Cohen , et al. Dec | 2019-12-31 |
| ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE App 20190314518 - ALLAN; Christian B. ; et al. | 2019-10-17 |
| Therapeutic use of anti-CS1 antibodies Grant 10,442,859 - Williams , et al. Oc | 2019-10-15 |
| Nucleic acid molecules encoding anti-CD40 antibodies Grant 10,400,041 - Cohen , et al. Sep | 2019-09-03 |
| Anti-cMet antibody drug conjugates and methods for their use Grant 10,383,948 - Allan , et al. A | 2019-08-20 |
| Anti-4-1bb Antibodies And Their Uses App 20190194329 - AKAMATSU; Yoshiko ; et al. | 2019-06-27 |
| Abt-165 In Combination With Folinic Acid, 5-fluorouracil, And Irinotecan For The Treatment Of Cancers App 20190167790 - Naumovski; Louie | 2019-06-06 |
| Anti-CS1 antibodies and antibody drug conjugates Grant 10,308,713 - Gish , et al. | 2019-06-04 |
| ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE App 20190105329 - GISH; Kurt C. ; et al. | 2019-04-11 |
| ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE App 20190105328 - GISH; Kurt C. ; et al. | 2019-04-11 |
| ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE App 20190099431 - GISH; Kurt C. ; et al. | 2019-04-04 |
| Bispecific binding proteins that bind CD40 and mesothelin Grant 10,233,258 - Akamatsu , et al. | 2019-03-19 |
| Anti-cd40 Antibodies And Their Uses App 20190071509 - Cohen; Diane Sau Mun ; et al. | 2019-03-07 |
| Vectors and host cells comprising a modified SV40 promoter for protein expression App 20190062797 - Hartman; Taymar E. ; et al. | 2019-02-28 |
| Anti-huLRRC15 antibody drug conjugates and methods for their use Grant 10,195,209 - Gish , et al. Fe | 2019-02-05 |
| Anti-huLRRC15 antibody drug conjugates and methods for their use Grant 10,188,660 - Gish , et al. Ja | 2019-01-29 |
| Fc variants with improved complement activation Grant 10,150,814 - Hinton , et al. Dec | 2018-12-11 |
| Anti-ox40 Antibodies And Their Uses App 20180346593 - HARDING; Fiona A. | 2018-12-06 |
| Fc Variants App 20180251565 - HARDING; Fiona A. ; et al. | 2018-09-06 |
| ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE App 20180250418 - AFAR; Daniel E.H. ; et al. | 2018-09-06 |
| Vectors and host cells comprising a modified SV40 promoter for protein expression Grant 10,053,720 - Hartman , et al. August 21, 2 | 2018-08-21 |
| Anti-cs1 Antibodies And Antibody Drug Conjugates App 20180222979 - GISH; Kurt C. ; et al. | 2018-08-09 |
| Anti-OX40 antibodies and their uses Grant 10,040,864 - Harding August 7, 2 | 2018-08-07 |
| Anti-CD40 antibodies Grant 10,023,645 - Cohen , et al. July 17, 2 | 2018-07-17 |
| Bispecific Binding Proteins App 20180194862 - AKAMATSU; Yoshiko ; et al. | 2018-07-12 |
| Anti-ox40 Antibodies And Their Uses App 20180194855 - HARDING; Fiona A. | 2018-07-12 |
| Anti-cd40 Antibodies And Their Uses App 20180186889 - COHEN; Diane Sau Mun ; et al. | 2018-07-05 |
| Anti-CS1 antibodies and antibody drug conjugates Grant 10,011,657 - Gish , et al. July 3, 2 | 2018-07-03 |
| Anti-ox40 Antibodies And Their Uses App 20180171023 - HARDING; Fiona A. | 2018-06-21 |
| Anti-pd-1 Antibodies And Their Uses App 20180148513 - AFAR; Daniel E.H. ; et al. | 2018-05-31 |
| Methods Of Treating Progressive Forms Of Multiple Sclerosis App 20180127507 - GREENBERG; Steven Jay ; et al. | 2018-05-10 |
| Dac Hyp Compositions And Methods App 20180127506 - HARTMAN; Taymar E. ; et al. | 2018-05-10 |
| Anti-pd-1 Antibodies And Their Uses App 20180072810 - AFAR; Daniel E.H. ; et al. | 2018-03-15 |
| Anti-PD-1 antibodies and their uses Grant 9,914,783 - Afar , et al. March 13, 2 | 2018-03-13 |
| ANTI-cMET ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE App 20170348429 - REILLY; EDWARD B. ; et al. | 2017-12-07 |
| Bispecific Binding Proteins App 20170342169 - AKAMATSU; Yoshiko ; et al. | 2017-11-30 |
| Method Of Treating Multiple Myeloma Using Combination Therapies Based On Anti-cs1 Antibodies App 20170342150 - AFAR; Daniel | 2017-11-30 |
| Anti-cd40 Antibodies And Their Uses App 20170342159 - COHEN; Diane Sau Mun ; et al. | 2017-11-30 |
| DAC HYP compositions Grant 9,815,903 - Hartman , et al. November 14, 2 | 2017-11-14 |
| Anti-VEGF antibodies and their uses Grant 9,815,893 - Akamatsu November 14, 2 | 2017-11-14 |
| Methods of treating progressive forms of multiple sclerosis comprising subcutaneously administering daclizumab Grant 9,809,652 - Greenberg , et al. November 7, 2 | 2017-11-07 |
| Dac Hyp Compositions App 20170247461 - HARTMAN; Taymar E. ; et al. | 2017-08-31 |
| Anti-cd25 Antibodies And Their Uses App 20170233481 - AKAMATSU; Yoshiko ; et al. | 2017-08-17 |
| DAC HYP compositions and methods Grant 9,676,860 - Hartman , et al. June 13, 2 | 2017-06-13 |
| ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE App 20170151344 - GISH; Kurt C. ; et al. | 2017-06-01 |
| Compositions And Methods For Producing Glycoproteins App 20170152540 - VARMA; Amit ; et al. | 2017-06-01 |
| ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE App 20170151343 - GISH; Kurt C. ; et al. | 2017-06-01 |
| CTLA4 proteins and their uses Grant 9,587,007 - Akamatsu , et al. March 7, 2 | 2017-03-07 |
| Vectors And Host Cells Comprising A Modified Sv40 Promoter For Protein Expression App 20160265018 - HARTMAN; TAYMAR E. ; et al. | 2016-09-15 |
| Compositions And Methods Using Anti-cs1 Antibodies To Treat Multiple Myeloma App 20160206734 - AFAR; Daniel | 2016-07-21 |
| Fc Variants With Improved Complement Activation App 20160137732 - HINTON; Paul R. ; et al. | 2016-05-19 |
| Method Of Treating Multiple Myeloma Using Combination Therapies Based On Anti-cs1 Antibodies App 20160137735 - AFAR; Daniel ; et al. | 2016-05-19 |
| DAC HYP compositions and methods Grant 9,340,619 - Hartman , et al. May 17, 2 | 2016-05-17 |
| Anti-cs1 Antibodies And Antibody Drug Conjugates App 20160122430 - Gish; Kurt C. ; et al. | 2016-05-05 |
| Anti-TNF-alpha antibodies and their uses Grant 9,315,573 - Harding , et al. April 19, 2 | 2016-04-19 |
| Methods for identifying antibodies with reduced immunogenicity Grant 9,279,016 - Harding , et al. March 8, 2 | 2016-03-08 |
| DAC HYP compositions and methods Grant 9,260,528 - Hartman , et al. February 16, 2 | 2016-02-16 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20160002335 - WILLIAMS; Marna ; et al. | 2016-01-07 |
| Therapeutic use of anti-CS1 antibodies Grant 9,175,081 - Williams , et al. November 3, 2 | 2015-11-03 |
| Anti-vegf Antibodies And Their Uses App 20150299307 - AKAMATSU; Yoshiko | 2015-10-22 |
| Dac Hyp Compositions And Methods App 20150274832 - HARTMAN; Taymar E. ; et al. | 2015-10-01 |
| Compositions And Methods For Producing Glycoproteins App 20150259425 - Varma; Amit ; et al. | 2015-09-17 |
| Dac Hyp Compositions And Methods App 20150203583 - HARTMAN; Taymar E. ; et al. | 2015-07-23 |
| Dac Hyp Compositions And Methods App 20150197573 - HARTMAN; Taymar E. ; et al. | 2015-07-16 |
| Method for treating psoriasis Grant 9,078,876 - Ehrhardt , et al. July 14, 2 | 2015-07-14 |
| Anti-VEGF antibodies and their uses Grant 9,079,953 - Harding , et al. July 14, 2 | 2015-07-14 |
| Method for treating psoriasis Grant 9,072,725 - Ehrhardt , et al. July 7, 2 | 2015-07-07 |
| Therapeutic use of anti-tweak receptor antibodies Grant 9,056,908 - Culp June 16, 2 | 2015-06-16 |
| Method Of Screening Complex Protein Libraries To Identify Altered Properties App 20150051081 - DuBridge; Robert ; et al. | 2015-02-19 |
| Ctla4 Proteins And Their Uses App 20150051158 - AKAMATSU; Yoshiko ; et al. | 2015-02-19 |
| Anti-HER2 antibodies and their uses Grant 8,937,159 - Harding , et al. January 20, 2 | 2015-01-20 |
| Anti-cd25 Antibodies And Their Uses App 20150010538 - AKAMATSU; YOSHIKO ; et al. | 2015-01-08 |
| Anti-cd25 Antibodies And Their Uses App 20150010539 - AKAMATSU; YOSHIKO ; et al. | 2015-01-08 |
| Fc Variants App 20140377253 - HARDING; Fiona A. ; et al. | 2014-12-25 |
| Compositions against cancer antigen LIV-1 and uses thereof Grant 8,906,342 - Law , et al. December 9, 2 | 2014-12-09 |
| CTLA4 proteins and their uses Grant 8,883,971 - Akamatsu , et al. November 11, 2 | 2014-11-11 |
| Methods Of Treating Multiple Myeloma Using Combination Therapies Based On Anti-cs1 Antibodies App 20140322201 - Afar; Daniel ; et al. | 2014-10-30 |
| Method For Treating Psoriasis App 20140314756 - Ehrhardt; Rolf O. ; et al. | 2014-10-23 |
| Methods For Identifying Antibodies With Reduced Immunogenicity App 20140227251 - HARDING; Fiona A. ; et al. | 2014-08-14 |
| Anti-tnf-alpha Antibodies And Their Uses App 20140212424 - Harding; Fiona A. ; et al. | 2014-07-31 |
| Anti-vegf Antibodies And Their Uses App 20140154255 - AKAMATSU; Yoshiko | 2014-06-05 |
| Anti-TNF-.alpha. antibodies and their uses Grant 8,722,860 - Harding , et al. May 13, 2 | 2014-05-13 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20140065063 - Williams; Marna ; et al. | 2014-03-06 |
| Anti-EGFR antibodies and their uses Grant 8,658,175 - Dubridge , et al. February 25, 2 | 2014-02-25 |
| Compositions Against Cancer Antigen Liv-1 And Uses Thereof App 20140037540 - LAW; DEBBIE ; et al. | 2014-02-06 |
| CTLA4 proteins and their uses Grant 8,642,557 - Akamatsu , et al. February 4, 2 | 2014-02-04 |
| Methods of screening complex protein libraries to identify altered properties Grant 8,633,139 - DuBridge , et al. January 21, 2 | 2014-01-21 |
| Alteration of Fc-fusion protein serum half-lives by mutagenesis Grant 8,624,007 - Hinton , et al. January 7, 2 | 2014-01-07 |
| Ctla4 Proteins And Their Uses App 20130330338 - AKAMATSU; Yoshiko ; et al. | 2013-12-12 |
| Use of anti-CS1 antibodies for treatment of rare lymphomas Grant 8,603,477 - Afar , et al. December 10, 2 | 2013-12-10 |
| Compositions against cancer antigen LIV-1 and uses thereof Grant 8,591,863 - Law , et al. November 26, 2 | 2013-11-26 |
| Stable aqueous pharmaceutical formulations of daclizumab antibodies Grant 8,465,739 - Kaisheva , et al. June 18, 2 | 2013-06-18 |
| Therapeutic use of anti-CS1 antibodies Grant 8,461,306 - Williams , et al. June 11, 2 | 2013-06-11 |
| Therapeutic use of anti-CS1 antibodies Grant 8,445,646 - Williams , et al. May 21, 2 | 2013-05-21 |
| Therapeutic use of anti-CS1 antibodies Grant 8,444,980 - Williams , et al. May 21, 2 | 2013-05-21 |
| Therapeutic use of anti-CS1 antibodies Grant 8,436,146 - Williams , et al. May 7, 2 | 2013-05-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 